0001415889-24-011469.txt : 20240424
0001415889-24-011469.hdr.sgml : 20240424
20240424181743
ACCESSION NUMBER: 0001415889-24-011469
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240423
FILED AS OF DATE: 20240424
DATE AS OF CHANGE: 20240424
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lowenthal Richard E
CENTRAL INDEX KEY: 0001378550
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39756
FILM NUMBER: 24872198
MAIL ADDRESS:
STREET 1: 12481 HIGH BLUFF DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARS Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001671858
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 811489190
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11682 EL CAMINO REAL, SUITE 120
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-771-9307
MAIL ADDRESS:
STREET 1: 11682 EL CAMINO REAL, SUITE 120
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Silverback Therapeutics, Inc.
DATE OF NAME CHANGE: 20160412
4
1
form4-04242024_100435.xml
X0508
4
2024-04-23
0001671858
ARS Pharmaceuticals, Inc.
SPRY
0001378550
Lowenthal Richard E
C/O ARS PHARMACEUTICALS, INC.
11682 EL CAMINO REAL, SUITE 120
SAN DIEGO
CA
92130
true
true
true
false
PRESIDENT AND CEO
0
Common Stock
4315313
D
Common Stock
2024-04-23
4
M
0
82733
0.84
A
3359587
I
By Spouse
Common Stock
2024-04-23
4
M
0
48260
1.44
A
3407847
I
By Spouse
Common Stock
1646494
I
By Richard Lowenthal Charitable Remainder UniTrust Dated January 7, 2020
Common Stock
1848499
I
By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006
Common Stock
1647447
I
By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020
Stock Option (right to buy)
0.84
2024-04-23
4
M
0
82733
0
D
2029-12-16
Common Stock
82733
0
I
By Spouse
Stock Option (right to buy)
1.44
2024-04-23
4
M
0
48260
0
D
2031-12-13
Common Stock
48260
34473
I
By Spouse
The Reporting Person is trustee of the trust.
The shares are held in trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are trustees of the trust.
The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date.
/s/ Kathleen Scott, Attorney-in-Fact
2024-04-24